Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Laboratory test for hepatitis C should be more reliable]

Wen-ge Xing¹, Huai-jing Zheng

¹National Center for Clinical Laboratories, Beijing Hosptial, Beijing 100730, China.

Zhonghua Gan Zang Bing Za Zhi = Zhonghua Ganzangbing Zazhi = Chinese Journal of Hepatology

|April 3, 2004

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Transarterial chemoembolization (TACE) combined with immunotherapy and anti-angiogenic agents in intermediate-stage hepatocellular carcinoma (CHANCE2202): a target trial emulation study.

EClinicalMedicine·2026

Same author

Predictors of recurrence after conversion therapy in unresectable hepatocellular carcinoma treated with HAIC, bevacizumab, and sintilimab.

Frontiers in immunology·2025

Same author

CT-Guided Lung Biopsy with Needle Embolization Using Gelatin Sponge Slurry to Prevent Pneumothorax and Pulmonary Hemorrhage: A Propensity Score Matching Controlled Study.

Academic radiology·2025

Same author

Comparison of effectiveness and cost of different HCV testing strategies in high-risk populations in China.

Journal of medical virology·2024

Same author

Development and evaluation of serological screening based on one dried plasma spot for HIV, syphilis, and HCV.

Virology journal·2023

Same author

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001).

Signal transduction and targeted therapy·2023